Cargando…
Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy
The treatment of cancer patients with α‐particle‐emitting therapeutics continues to gain in importance and relevance. The range of radiopharmaceutically relevant α‐emitters is limited to a few radionuclides, as stable chelators or carrier systems for safe transport of the radioactive cargo are often...
Autores principales: | Reissig, Falco, Zarschler, Kristof, Hübner, René, Pietzsch, Hans‐Jürgen, Kopka, Klaus, Mamat, Constantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397357/ https://www.ncbi.nlm.nih.gov/pubmed/32775141 http://dx.doi.org/10.1002/open.202000126 |
Ejemplares similares
-
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
por: Reissig, Falco, et al.
Publicado: (2021) -
Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging †
por: Reissig, Falco, et al.
Publicado: (2020) -
Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
por: Gilpin, Ian Moore F., et al.
Publicado: (2021) -
Efficient Production of the PET Radionuclide (133)La for Theranostic Purposes in Targeted Alpha Therapy Using the (134)Ba(p,2n)(133)La Reaction
por: Brühlmann, Santiago Andrés, et al.
Publicado: (2022) -
Modified Calix[4]crowns as Molecular Receptors for Barium
por: Steinberg, Janine, et al.
Publicado: (2018)